This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 May;50(5):1203-5.

doi: 10.1212/wnl.50.5.1203.

Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?

PMID: 9595961
DOI: 10.1212/wnl.50.5.1203

Editorial

Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?

D S Knopman. Neurology. 1998 May.

. 1998 May;50(5):1203-5.

doi: 10.1212/wnl.50.5.1203.

Author

PMID: 9595961
DOI: 10.1212/wnl.50.5.1203

No abstract available

PubMed Disclaimer

Comment in

Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
Sandson TA. Sandson TA. Neurology. 1999 Feb;52(3):675-6. doi: 10.1212/wnl.52.3.673-b. Neurology. 1999. PMID: 10025821 No abstract available.

Comment on

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.
Cummings JL, Cyrus PA, Bieber F, Mas J, Orazem J, Gulanski B. Cummings JL, et al. Neurology. 1998 May;50(5):1214-21. doi: 10.1212/wnl.50.5.1214. Neurology. 1998. PMID: 9595966 Clinical Trial.
Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B. Morris JC, et al. Neurology. 1998 May;50(5):1222-30. doi: 10.1212/wnl.50.5.1222. Neurology. 1998. PMID: 9595967 Clinical Trial.

Similar articles

Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
Sandson TA. Sandson TA. Neurology. 1999 Feb;52(3):675-6. doi: 10.1212/wnl.52.3.673-b. Neurology. 1999. PMID: 10025821 No abstract available.
Metrifonate: update on a new antidementia agent.
Ringman JM, Cummings JL. Ringman JM, et al. J Clin Psychiatry. 1999 Nov;60(11):776-82. J Clin Psychiatry. 1999. PMID: 10584768 Review.
New drug treatment for Alzheimer's disease. Treatment with metrifonate warrants multicentre trials.
Zamar AC, Wise ME, Watson JP. Zamar AC, et al. BMJ. 1998 Oct 3;317(7163):946. BMJ. 1998. PMID: 9841012 No abstract available.
Metrifonate for Alzheimer's disease patients.
Schneider LS. Schneider LS. J Clin Psychiatry. 2000 Mar;61(3):218-9. doi: 10.4088/jcp.v61n0312d. J Clin Psychiatry. 2000. PMID: 10817111 No abstract available.
Metrifonate: overview of safety and efficacy.
Cummings JL. Cummings JL. Pharmacotherapy. 1998 Mar-Apr;18(2 Pt 2):43-6; discussion 79-82. Pharmacotherapy. 1998. PMID: 9543464 Review.

See all similar articles

Cited by

The cholinergic hypothesis of Alzheimer's disease: a review of progress.
Francis PT, Palmer AM, Snape M, Wilcock GK. Francis PT, et al. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47. doi: 10.1136/jnnp.66.2.137. J Neurol Neurosurg Psychiatry. 1999. PMID: 10071091 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information